Tizanidine Hydrochloride Capsule
Product Images NDC 72789-507

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine Hydrochloride (NDC 72789-507). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789507 Label (72789507)

This text provides information about a medication containing 4 mg of tizanidine hydrochloride. It instructs to refer to the package insert for prescribing details, store at room temperature, dispense in child-resistant containers, and keep out of reach of children. The medication is marketed and packaged by PD-Rx Pharmaceuticals, Inc. There are 150 capsules in the container, and the expiration date is 02/2025. Additional inquiries can be directed to PD-Rx Pharmaceuticals, Inc.*

FDA Label Image

Figure 1 (Tizanidine Hydrochloride Capsules Figure 1)

FDA Label Image

Figure 2 (Tizanidine Hydrochloride Capsules Figure 2)

FDA Label Image

Figure 3 (Tizanidine Hydrochloride Capsules Figure 3)

This text discusses the medication Tizanidine and its use in a study comparing its effects to a placebo, focusing on the improvement in Ashworth Score. It mentions the dosing of Tizanidine and study endpoints at week 3, week 7, and the last observation carried forward.*

FDA Label Image

Chemical Structural Formula (Tizanidine Hydrochloride Capsules Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.